Walleye Trading Advisors »

Halozyme Therapeutics shares owned by Walleye Trading Advisors

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Walleye Trading Advisors from 13F filings

Historical chart of Walleye Trading Advisors investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Walleye Trading Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Walleye Trading Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $5.3M 130k 40.68
2023-12-31 $3.6M 97k 36.96
2023-09-30 $8.7M 228k 38.20
2023-06-30 $527k 15k 36.07
2022-12-31 $1.9M 33k 56.90
2022-09-30 $218k 5.5k 39.61
2022-06-30 $500k 11k 43.97
2021-12-31 $348k 8.7k 40.17
2019-09-30 $327k 21k 15.50
2019-06-30 $869k 51k 17.17